Mia's Feed
Medical News & Research

Largest Study Links Elevated Lipoprotein(a) Levels to Increased Heart Disease Risk

Largest Study Links Elevated Lipoprotein(a) Levels to Increased Heart Disease Risk

Share this article

2 min read

A groundbreaking investigation into lipoprotein(a), or Lp(a), has revealed a significant connection between elevated levels of this lipid and heightened risks of cardiovascular events. Conducted by the Family Heart Foundation, this extensive study analyzed data from 273,770 individuals living with cardiovascular disease, making it the largest of its kind. The research demonstrated that any increase in Lp(a) levels correlates with a higher probability of serious events such as heart attacks, strokes, and the need for various cardiac procedures.

Presented at the European Atherosclerosis Society Congress in Glasgow and published in the European Heart Journal, the findings challenge previous notions that risk plateaus at certain Lp(a) levels. Instead, the data show a continuous rise in risk with increasing Lp(a), regardless of initial cardiovascular condition, gender, or race.

The study categorized participants based on their Lp(a) levels, revealing that women and Black individuals tend to have higher levels. Notably, every 1 nmol/L increase in Lp(a) was associated with an incremental rise in the risk of subsequent cardiovascular events.

Currently, no approved medications can effectively lower Lp(a) levels, although several investigational drugs are in late-stage trials. Interestingly, the research also suggests that intensive LDL-C lowering therapies, such as high-dose statins and PCSK9 inhibitors, may help mitigate the risk among those with very high Lp(a) levels.

This comprehensive study underscores the importance of measuring Lp(a) as part of cardiovascular risk assessment. It highlights the potential benefits of targeted treatment strategies and emphasizes the need for increased awareness and testing across populations, especially among those with existing cardiovascular disease.

Overall, the research signifies a vital step forward in understanding how lipoprotein(a) impacts heart health, paving the way for more personalized and effective prevention and treatment approaches.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Brain-Computer Interface Enables Real-Time Voice Synthesis for ALS Patients

UC Davis researchers have developed a cutting-edge brain-computer interface that enables ALS patients to speak in real time by translating brain signals into audible speech, offering new hope for those with speech loss.

Germany's BioNTech Acquires CureVac to Accelerate Cancer Research Using mRNA Technology

Germany's BioNTech is acquiring CureVac for $1.25 billion to strengthen its mRNA technology platform and accelerate the development of innovative cancer immunotherapies, marking a significant move in biotech research.

Innovative Pulsating Microneedles Offer Painless Transdermal Drug Delivery

Emerging pulsating microneedles provide a pain-free, scalable solution for transdermal drug delivery, revolutionizing how medications are administered without traditional needles.

Study Finds Brainwaves Synchronize During Live Dance Performances

A groundbreaking study shows that live dance performances can synchronize brain activity among viewers, emphasizing the social nature of shared artistic experiences.